Discover how low-dose IL-2 for ALS prolongs survival and slows progression in biomarker-defined patient subsets. Read more at AMJ.

COVID-19 was associated with increased allergic disease risk over 18 months, with differing findings in children and service ...

Machine learning predicted colorectal cancer liver metastases recurrence and survival, with dynamic models improving risk ...

Phase 3 results show pembrolizumab–olaparib prolonged progression-free survival in BRCA non-mutated advanced ovarian cancer.

Biological ageing-related plasma proteomics improves chronic liver disease prediction, adding more predictive value than ...

Analysis of 84,128 people finds TB preventive treatment can offer long-term protection, particularly in lower-burden settings.

GLP-1 nail disorders were more common among users, with nail detachment reported more than four times as often as in controls ...

Weekly petrelintide amylin produced up to 10.7% weight loss in adults with overweight or obesity, trial results show.

Coronary heart disease screening accuracy improved when AI combined tongue and facial images in a multimodal model.

Ustekinumab plus exclusive enteral nutrition was associated with improved clinical and endoscopic outcomes in Crohn’s disease ...

A small observational study suggests ultra-low-dose induction may help children with severe peanut or walnut allergies begin ...

A study of 250 mother-child pairs links prenatal aromatic amine exposure with differences in infant attention and recognition ...